Pharmacosmos, an international brand in the pharmaceutical industry, is dedicated to addressing iron deficiency, a common cause of anemia worldwide. Iron, an essential nutrient acquired through food, plays a crucial role in oxygen transport, oxidative metabolism, and cellular growth. It is a vital component of hemoglobin, the protein present in red blood cells that carries oxygen to tissues and organs.

Iron deficiency can lead to a decrease in hemoglobin levels, resulting in iron deficiency anemia. Apart from iron deficiency, Pharmacosmos acknowledges other factors contributing to anemia, including nutritional deficiencies, inflammation, parasitic infections, and disorders affecting hemoglobin or red blood cell production. The World Health Organization sets anemia thresholds at a hemoglobin level below 12 g/dl for non-pregnant adult women and below 13 g/dl for adult men.

With a mission to revolutionize the prevention and treatment of iron deficiency in both humans and animals, Pharmacosmos aims to enhance the well-being of individuals through innovative solutions. Their commitment to addressing iron deficiency aligns with their aspirations and values, as they prioritize patient care and strive for sustainable practices